Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cope

Showing results (11-20 of 187) with videos related to

Pageof 19
Sort By:
Clinical Therapeutics|June 15, 2019
Considerations for Optimal Trial Design for Rheumatoid Arthritis Prevention StudiesAndrew P Cope
Current Opinion in Immunology|October 30, 2004
Emerging approaches for the therapy of autoimmune and chronic inflammatory diseaseAndrew P Cope, Marc Feldmann
Springer Seminars in Immunopathology|December 4, 1998
Evaluating candidate autoantigens in rheumatoid arthritisA P Cope, G Sønderstrup
Clinical Medicine (London, England)|June 3, 2015
The ying and yang of fever in rheumatic diseaseJames Galloway, Andrew P Cope
The Journal of Rheumatology|March 1, 1995
Soluble tumor necrosis factor receptors in arthritisA P Cope, R N Maini
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2026
T cells in osteoarthritis; drivers, repairers or bystanders in osteoarthritis?Tonia L Vincent, Andrew P Cope
British Journal of Rheumatology|November 1, 1992
Cytokine measurements in biological fluidsA P Cope, F M Brennan
Best Practice & Research. Clinical Rheumatology|May 6, 2008
Immune-mediated pathways in chronic inflammatory arthritisClaire L Gorman, Andrew P Cope
Journal of Advanced Nursing|April 12, 2000
Situated learning in the practice placementP Cope, P Cuthbertson, B Stoddart
Arthritis Research|July 11, 2002
22nd European Workshop for Rheumatology Research, Leiden, The Netherlands, 28 February-3 March 2002Andrew P Cope, Hendrik Schulze-Koops
Pageof 19

Showing results (11-20 of 187) with videos related to

Sort By:
Pageof 19
Clinical Therapeutics|June 15, 2019
Considerations for Optimal Trial Design for Rheumatoid Arthritis Prevention StudiesAndrew P Cope
Current Opinion in Immunology|October 30, 2004
Emerging approaches for the therapy of autoimmune and chronic inflammatory diseaseAndrew P Cope, Marc Feldmann
Springer Seminars in Immunopathology|December 4, 1998
Evaluating candidate autoantigens in rheumatoid arthritisA P Cope, G Sønderstrup
Clinical Medicine (London, England)|June 3, 2015
The ying and yang of fever in rheumatic diseaseJames Galloway, Andrew P Cope
The Journal of Rheumatology|March 1, 1995
Soluble tumor necrosis factor receptors in arthritisA P Cope, R N Maini
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2026
T cells in osteoarthritis; drivers, repairers or bystanders in osteoarthritis?Tonia L Vincent, Andrew P Cope
British Journal of Rheumatology|November 1, 1992
Cytokine measurements in biological fluidsA P Cope, F M Brennan
Best Practice & Research. Clinical Rheumatology|May 6, 2008
Immune-mediated pathways in chronic inflammatory arthritisClaire L Gorman, Andrew P Cope
Journal of Advanced Nursing|April 12, 2000
Situated learning in the practice placementP Cope, P Cuthbertson, B Stoddart
Arthritis Research|July 11, 2002
22nd European Workshop for Rheumatology Research, Leiden, The Netherlands, 28 February-3 March 2002Andrew P Cope, Hendrik Schulze-Koops
Pageof 19